ProQR Therapeutics N.V.

PRQR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$28-$28-$64-$61
Dep. & Amort.$3$3$3$2
Deferred Tax-$0-$0$0$0
Stock-Based Comp.$3$3$3$6
Change in WC-$13$49-$5$25
Other Non-Cash-$0-$5-$5$1
Operating Cash Flow-$36$22-$69-$26
Investing Activities
PP&E Inv.-$1-$1-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$17$0$0$0
Inv. Sales/Matur.$17$0$0$0
Other Inv. Act.-$3$6$0$0
Investing Cash Flow-$4$4-$1-$0
Financing Activities
Debt Repay.-$2-$3-$45$27
Stock Issued$72$0$14$108
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$2
Financing Cash Flow$70-$2-$31$137
Forex Effect$1$1$7$1
Net Chg. in Cash$30$24-$93$112
Supplemental Information
Beg. Cash$119$95$188$76
End Cash$149$119$95$188
Free Cash Flow-$38$20-$69-$26
ProQR Therapeutics N.V. (PRQR) Financial Statements & Key Stats | AlphaPilot